Literature DB >> 8297524

Myasthenia gravis.

N Willcox1.   

Abstract

The cause of the myasthenics' pathogenic autoantibody response against the muscle acetylcholine receptor is an intriguing puzzle involving the thymus and its epithelial tumours, and possibly a variety of cross-reacting epitopes. Another fascinating challenge is to find ways of selectively inhibiting this response in the patients.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8297524     DOI： 10.1016/0952-7915(93)90105-2

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN： 0952-7915            Impact factor:   7.486


  20 in total

1.  Anti-voltage-gated potassium channel Kv1.4 antibodies in myasthenia gravis.

Authors:  Fredrik Romi; Shigeaki Suzuki; Norihiro Suzuki; Axel Petzold; Gordon T Plant; Nils Erik Gilhus
Journal:  J Neurol       Date:  2011-12-14       Impact factor: 4.849

2.  Pleiotropic effects of the 8.1 HLA haplotype in patients with autoimmune myasthenia gravis and thymus hyperplasia.

Authors:  Claire Vandiedonck; Geneviève Beaurain; Matthieu Giraud; Catherine Hue-Beauvais; Bruno Eymard; Christine Tranchant; Philippe Gajdos; Jean Dausset; Henri-Jean Garchon
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-15       Impact factor: 11.205

3.  Antibodies to acetylcholine receptors in patients with different clinical forms of myasthenia and Lambert-Eaton myasthenic syndrome.

Authors:  D V Sidnev; M Yu Karganov; N I Shcherbakova; I B Alchinova; A G Sanadze
Journal:  Neurosci Behav Physiol       Date:  2007-02

4.  A pathogenetic role for the thymoma in myasthenia gravis. Autosensitization of IL-4- producing T cell clones recognizing extracellular acetylcholine receptor epitopes presented by minority class II isotypes.

Authors:  N Nagvekar; A M Moody; P Moss; I Roxanis; J Curnow; D Beeson; N Pantic; J Newsom-Davis; A Vincent; N Willcox
Journal:  J Clin Invest       Date:  1998-05-15       Impact factor: 14.808

5.  The Integrated Genomic Landscape of Thymic Epithelial Tumors.

Authors:  Milan Radovich; Curtis R Pickering; Ina Felau; Gavin Ha; Hailei Zhang; Heejoon Jo; Katherine A Hoadley; Pavana Anur; Jiexin Zhang; Mike McLellan; Reanne Bowlby; Thomas Matthew; Ludmila Danilova; Apurva M Hegde; Jaegil Kim; Mark D M Leiserson; Geetika Sethi; Charles Lu; Michael Ryan; Xiaoping Su; Andrew D Cherniack; Gordon Robertson; Rehan Akbani; Paul Spellman; John N Weinstein; D Neil Hayes; Ben Raphael; Tara Lichtenberg; Kristen Leraas; Jean Claude Zenklusen; Junya Fujimoto; Cristovam Scapulatempo-Neto; Andre L Moreira; David Hwang; James Huang; Mirella Marino; Robert Korst; Giuseppe Giaccone; Yesim Gokmen-Polar; Sunil Badve; Arun Rajan; Philipp Ströbel; Nicolas Girard; Ming S Tsao; Alexander Marx; Anne S Tsao; Patrick J Loehrer
Journal:  Cancer Cell       Date:  2018-02-12       Impact factor: 31.743

6.  Potent immunostimulatory dendritic cells can be cultured in bulk from progenitors in normal infant and adult myasthenic human thymus.

Authors:  M E Hill; D J Ferguson; J M Austyn; J Newsom-Davis; H N Willcox
Journal:  Immunology       Date:  1999-06       Impact factor: 7.397

7.  Presentation of endogenous acetylcholine receptor antigen to a specific CD4+ T-cell line by a transfected B-cell line.

Authors:  A F Mulcahy; D M Beeson; N Willcox; A G Diamond
Journal:  Immunology       Date:  1995-09       Impact factor: 7.397

8.  Circulating regulatory anti-T cell receptor antibodies in patients with myasthenia gravis.

Authors:  Florence Jambou; Wei Zhang; Monique Menestrier; Isabelle Klingel-Schmitt; Olivier Michel; Sophie Caillat-Zucman; Abderrahim Aissaoui; Ludovic Landemarre; Sonia Berrih-Aknin; Sylvia Cohen-Kaminsky
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

9.  The significance of titin antibodies in myasthenia gravis--correlation with thymoma and severity of myasthenia gravis.

Authors:  Xiang-Jun Chen; Jian Qiao; Bao-Guo Xiao; Chuan-Zhen Lu
Journal:  J Neurol       Date:  2004-08       Impact factor: 4.849

10.  Thymopoiesis, regulatory T cells, and TCRVbeta expression in thymoma with and without myasthenia gravis, and modulatory effects of steroid therapy.

Authors:  Andrea Fattorossi; Alessandra Battaglia; Alexia Buzzonetti; Giacomo Minicuci; Raffaella Riso; Laura Peri; Giovanni Scambia; Amelia Evoli
Journal:  J Clin Immunol       Date:  2007-11-14       Impact factor: 8.317
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.